VERNON, BC, Nov. 25, 2022 /CNW/ – Doseology Sciences Inc. (CSE: MOOD)(OTC QB: DOSEF)(FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce that its mushroom supplements will soon be available nationwide. which is 14 top-tier Whole Foods Market locations in Canada.
The Company launched 3 leading SKUs – the SLEEP, WAKE, and ELEVATE functional mushroom tinctures. Doseology products can now be found at Whole Foods Market western retail locations at West Vancouver, North Vancouver, Vancouverand North Burnabyand will soon be available at all Canadian retail locations.
“Whole Foods has a reputation as an industry leader with the highest standards, which makes them an ideal retail partner for our products. This placement will help us create brand awareness and increase those sales, while delivering health and wellness results for customers,” said Ralph OlsonCEO of the Company.
The line is made with 100% fruiting body mushrooms and adaptogenic plants, and is designed for wellness seekers interested in daily support for cognition, mood, immunity and relaxation.
Approximately 30% of Canadians suffer from a sleep disorder (The Sleep Foundation). Sleep affects mental health and physical well-being, and is associated with many mood disorders, including depression and anxiety (Provincial Health Services Authority). To address this issue, Doseology formulated it sleep tincture. The proprietary blend of reishi mushroom, chamomile and melatonin is a powerful tool that brings the body and mind to a peaceful state and improves the quality of sleep. The Reishi mushroom (Ganoderma lucidum), also known as the “Mushroom of Immortality”, has been used for centuries to relieves stress and anxiety.
Mornings are filled with Doseology WAKE tincture. It’s a stimulating blend of lion’s mane mushroom, yerba mate and B vitamins to promote alertness and mental clarity. Wake was recently spotted in Elle Gourmet’s “Four surprising health trends for 2023“.
The Doseology ELEVATE The tincture contains lion’s mane, the mushroom known to unlock cognitive potential, and is formulated with a nutritious dose of ginger and vitamin B3. These conscious ingredients work synergistically to provide support for the overall condition.
On behalf of Doseology Sciences Inc.
Chief Executive Officer
About Whole Foods Market
For more than 40 years, Whole Foods Market has been a leading natural and organic food retailer. Whole Foods seeks out the best natural and organic foods available, maintains the strictest quality standards in the industry, and has an unwavering commitment to sustainable agriculture. Whole Foods has more than 500 stores in the US, Canada and the United Kingdom. It has 14 retail locations in Canadaof which 7 are in the British Columbiaand 7 in Ontario. Whole Foods is a subsidiary of Amazon (Nasdaq: AMZN).
About Doseology Sciences (CSE: MOOD)(OTCQB: DOSEF)(FSE: VU7)
Doseology Sciences Inc. has built a progressive brand focused on mental health and wellness by cultivating, sourcing and innovative nutraceutical and pharmaceutical products. Doseology aims to make a meaningful impact on the mental health pandemic through the use and development of functional fungi and plant-derived medicines. With a vertically integrated approach, Doseology aims to process and distribute products at its facilities in Vernon, British Columbia, in accordance with applicable laws to ensure safe and high quality production. Doseology medicinal mushroom products, including tinctures, powders and supplements, are available at doseology.com.
This press release contains statements that constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information is often identified by the words “may,” “will,” “could,” “should,” “will,” “intend,” “plan,” “expect,” “believe,” ” estimate,” “expect” or similar expressions. Readers are cautioned that forward-looking information is not based on historical facts but rather reflects the expectations, estimates or projections of the Company’s management regarding the Company’s future business results or events based on opinion, assumptions and estimates of management considered reasonable as of the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, because the unknown -an or unpredictable factors may have material adverse effects on future results, performance. , or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes -or in the financial markets; decrease in the prevailing prices of the products in the markets in which the Company operates; adverse changes in applicable laws or adverse changes in the application or enforcement of current laws; regulations and enforcement priorities of government authorities; compliance with government regulation and related costs; and other risks described in the Company’s prospectus. If one or more of these risks or uncertainties materialize, or if the assumptions underlying the forward-looking information prove incorrect, actual results may differ materially from those described herein as intended, planned, expected, believed, estimated, or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be other reasons that results may not be as expected, estimated or intended. . The Company does not intend, and does not assume any obligation, to update this information going forward except as required by applicable law. For additional information, investors should review the Company’s filings available at cedar.
No securities regulatory authority has approved or disapproved of the content of this news release. The securities of the Company have not been, nor have they been, registered under the United States Securities Act of 1933, as amended, or any other state securities laws, and may not be offered or sold in in the United Statesor to or for the account or benefit of any person in in the United States, absent registration, or an appropriate exemption from registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of in the United Statesor in any other jurisdiction where such offer, solicitation or sale would be unlawful.
CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Doseology Sciences Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2022/25/c5549.html